awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36155239-DC5AF8E3-DFD2-4B33-B97C-AB9512C03CDF
Q36155239-DC5AF8E3-DFD2-4B33-B97C-AB9512C03CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36155239-DC5AF8E3-DFD2-4B33-B97C-AB9512C03CDF
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
P2860
Q36155239-DC5AF8E3-DFD2-4B33-B97C-AB9512C03CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36155239-DC5AF8E3-DFD2-4B33-B97C-AB9512C03CDF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b84f43aa613fd05cdf5a147a412717e2486b500
P2860
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.